AbbVie
$254.68+0.19Capitalización de mercado
$504.8B
Puesto mundial
#24
Máximo histórico
$510.8B
2026-10-21
Crecimiento total
+0%
desde 2026
Market Cap Context
- Larger than 93% of the 367 companies we track (globally).
- Equivalent to 1.6% of United States's GDP (2025 data).
- Just above: #23 Mastercard ($542.2B)
- Just below: #25 Intel ($459.7B)
- Best year: 2017 (+60%). Worst year: 2015 (-7%).
AbbVie Financial Breakdown (FY 2025)
Source: Yahoo Finance — ABBV annual filings (2025) →$61.2B revenue · $20.1B operating income · $4.2B net income
- ●Operating margin: 32.8% on $61.2B in revenue.
- ●R&D is 14.9% of revenue ($9.1B).
- ●Net income margin: 6.9% — $4.2B in profit.
- ●Free cash flow: $17.8B (29.1% of revenue).
Cost / Operating Expenses
Total operating expenses $41.1B
Total
$41.3B
Capital Expenditures
$1.2B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$17.8B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
124.9
EPS
$2.05
Net margin
5.8%
ROE
68.0%
Dividend yield
2.68%
Debt / Equity
2.65
Acerca de AbbVie
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Historial de capitalización de mercado de AbbVie (2026–2026)
AbbVie vs Sector Peers by Market Cap
Comparar AbbVie
Historial de clasificación
| Año | Capitalización de mercado | Puesto | Variación interanual |
|---|---|---|---|
| 2026 | $504.8B | #24 | +27.1% |
| 2025 | $397.2B | #24(↑4) | +33.1% |
| 2024 | $298.5B | #28(↑3) | +18.9% |
| 2023 | $251.1B | #31(↓5) | -0.2% |
| 2022 | $251.7B | #26(↑20) | +24.0% |
| 2021 | $203.0B | #46 | +32.4% |
| 2020 | $153.3B | #46(↑7) | +27.7% |
| 2019 | $120.0B | #53(↓17) | +1.5% |
| 2018 | $118.3B | #36 | -1.0% |
| 2017 | $119.4B | #36(↑15) | +60.1% |
| 2016 | $74.6B | #51(↑2) | +9.8% |
| 2015 | $67.9B | #53(↓4) | -6.5% |
| 2014 | $72.7B | #49(↑5) | +27.9% |
| 2013 | $56.8B | #54 |
Otras empresas del sector Salud
Preguntas frecuentes
What is AbbVie Inc.'s market cap?
AbbVie Inc. (ABBV) has a market capitalization of $504.8B, making it the #24 largest company in the world by market cap.
What was AbbVie Inc.'s highest market cap?
AbbVie Inc.'s all-time high market cap was $510.8B, reached in 2026-10-21. Its highest rank was #24 in 2026.
What sector is AbbVie Inc. in?
AbbVie Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has AbbVie Inc.'s market cap changed over time?
AbbVie Inc. has been tracked since 2026. Its market cap has grown by 0% from $504.8B in 2026 to $504.8B today.